Quantum Biosystems, a Japan-based life sciences firm founded in 2013, has secured ¥2.4 billion ($20.5m) in a venture round backed by Tokyo University.
The institution made its investment through its venture arm, Edge Capital. Also joining the round were state-backed Innovation Network Corporation of Japan, private equity firm Jafco, Mizuho Capital, and Mitsubishi UFJ Capital, the corporate venture capital arm of conglomerate Mitsubishi.
The company is developing genome sequencing equipment to compete with similar platforms developed by pharmaceutical firm Roche.…
